GlaxoSmithKline Inc.
| Specific Topics of Lobbying Communications | Intended Outcomes | Associated Subject Matters |
|---|---|---|
|
Advocacy as it relates to Patended Medicines Pricing Review Board and its potential impact on BC's Life Sciences and Research Community
|
Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Advanced Education, COVID-19, Economic Development and Trade, Health
|
|
Advocacy related to pharmaceutical and health sciences research
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Advanced Education, COVID-19, Economic Development and Trade, Health, Hospitals, Industry
|
|
Discussions regarding pharmaceutical and vaccine procurement, drug and vaccine listings on publicly funded programs and other issues related to access to GSK medicines
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Industry
|
|
GSK will conduct activities related to advancement of GSK medicines and vaccines with stakeholders of the healthcare system.
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
COVID-19, Economic Development and Trade, Finances and Budgets, Health, Hospitals, Industry
|
|
GSK will meet to discuss issues related to access to GSK Medicines and Vaccines, clinical trials and advancement of the life sciences industry
|
Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation, Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity, Introduction, amendment, passage or defeat of any Bill or resolution in or before the Legislative Assembly, Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly, Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
|
Advanced Education, COVID-19, Economic Development and Trade, Government Procurement, Health, Hospitals, Industry
|
|
Meeting with Government and Healthcare officials to discuss pharmaceutical and health policy, economic development as it relates to clinical trials and other research, scientific information related to GSK's portfolio of medicines and vaccines.
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
COVID-19, Economic Development and Trade, Health, Hospitals, Intellectual Property, Science and Technology
|
|
Opportunities for collaboration re: Green BC
|
Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
|
Environment, Health, Science and Technology
|